Hyperviscosity in plasma cell dyscrasias

Clinical Hemorheology and Microcirculation

Volumn 55, Issue 1, 2013, Pages 75-83

  Kwaan, Hau C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Hyperviscosity; myeloma; plasma cell dyscrasias; plasmapheresis; Waldenstrom's macroglobulinemia

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; PADGEM PROTEIN; PARAPROTEIN; PLASMA PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE HEART INFARCTION; BIOLOGICAL THERAPY; BLOOD LEVEL; BLOOD VISCOSITY; CELL PROLIFERATION; CONGESTIVE HEART FAILURE; CRYOGLOBULINEMIA; DIZZINESS; ERYTHROCYTE AGGREGATION; ERYTHROCYTE SEDIMENTATION RATE; HEADACHE; HEALTH CARE QUALITY; HEART FAILURE; HUMAN; HYPERVISCOSITY SYNDROME; KIDNEY FAILURE; LUNG BLOOD FLOW; MOLECULAR SIZE; MONOCLONAL IMMUNOGLOBULINEMIA; NEUROLOGICAL COMPLICATION; PLASMA CELL; PLASMA CELL DYSCRASIA; PLASMA VISCOSITY; PLASMA VOLUME; PLASMAPHERESIS; PROTEIN CONTENT; PROTEIN EXPRESSION; REVIEW; STEM CELL TRANSPLANTATION; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; TRANSIENT ISCHEMIC ATTACK; VEIN THROMBOSIS; VENOUS CIRCULATION; WALDENSTROEM MACROGLOBULINEMIA;

HYPERVISCOSITY; MYELOMA; PLASMA CELL DYSCRASIAS; PLASMAPHERESIS; WALDENSTROM'S MACROGLOBULINEMIA;

BLOOD VISCOSITY; DISEASE PROGRESSION; ERYTHROCYTE AGGREGATION; HEMORRHAGE; HUMANS; PARAPROTEINEMIAS; PLASMAPHERESIS; WALDENSTROM MACROGLOBULINEMIA;

EID: 84887932283     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-131691     Document Type: Review

References (35)

1. A. Alatoom, R. Elsabrouty, J. Willis, C. Boils, R. Sarode, I. Hashim and H.Y. Wang, Fatal cerebral hemorrhage in a patient with CD19-positive IgM-producing aggressive plasma cell myeloma, hyperviscosity syndrome and cryoglobulinemia, Int J Clin Exp Pathol 2 (2009), 498-507
2. B. Almog, R. Gamzu, R. Almog, J.B. Lessing, I. Shapira, S. Berliner, et al, Enhanced erythrocyte aggregation in clinically diagnosed pelvic inflammatory disease, Sexually transmitted diseases 32 (2005), 484-496
3. K.C. Anderson, M. Alsina, W. Bensinger, et al. Waldenstrom's macroglobulimia/ lymphoplasmacytic lymphoma, version 2.2013, J Natl Compr Canc Netw 10 (2012), 1211-1219
4. M. Ballestri, F. Ferrari, R. Magistroni, M. Mariano, G.B. Checherelli, G. Milanti, et al. Plasma exchange in acute and chronic hyperviscosity syndrome: A rheological approach and guidelines study, Ann Ist Super Sanita 43 (2007), 171-175
5. O.K. Baskurt and H.J. Meiselman, Erythrocyte aggregation: Basic aspects and clinical importance, Clin Hemorheol Microcirc 53 (2013), 23-37
6. W. Bell ed, Defibrinogenation by Arvin Stuttgard: F.A. Schattauer Verlag, 1973
7. H. Brenner, A. Gondos and D. Pulte, Recent major improvement in long-term survival of younger patients with multiple myeloma, Blood 111 (2008), 2521-2526
8. S. Chen, A. Eldor, G. Barshtein, S. Zhang, A. Goldfarb, E. Rachmilewitz and S. Yedgar, Enhanced aggregability of red blood cells of beta-thalassemia major patients, Am J Physiol Heart Circ Physiol 27 (1996), H1951-H1956
9. J.Z. Ciejka, E.B. Cook, D. Lawler, J. Martin, R.D. Woodson and F. Graziano, Severe cold agglutinin disease and cryoglobulinemia secondary to a monoclonal anti-Pr2 IgM lambda cryoagglutinin, Clin Exper Rheumatol 17 (1999), 227-231
10. J. Crawford, E.B. Cox and H.J. Cohen, Evaluation of hyperviscosity in monoclonal gammopathies, Am J Med 79 (1985), 13-22
11. G. DiMinno, F. Coraggio, A.M. Cerbone, A.M. Capitanio, C. Manzo, M. Spina, et al., A myeloma paraprotein with specificity for platelet glycoprotein IIIa in a patient with a fatal bleeding disorder, J Clin Invest 77 (1986), 157-164
12. M.A. Dimopoulos, R.A. Kyle, A. Anagnostopoulos and S.P. Treon, Diagnosis and management of Waldenstrom's macroglobulinemia, J. Clin. Oncol 23 (2005), 1564-1577
13. A.B. Federici, F. Stabile, G. Castaman, M.T. Canciani and P.M. Mannucci, Treatment of acquired vonWillebrand syndrome in patients with monoclonal gammopathy of uncertain significance: Comparison of three different therapeutic approaches, Blood 92 (1998), 2707-2711
14. M.A. Gertz, Cold agglutinin disease, Haematologica 91 (2006), 439-441
15. M.A. Gertz, Waldenstrom macroglobulinemia: 2012 update on diagnosis, risk stratification, and management, AmJ Hematol 87 (2012), 503-510
16. I.M. Ghobrial, Are you sure this is Waldenstrom macroglobulinemia? Hematology Am Soc Hematol Educ Program 2012 (2012), 586-594
17. A. Jemal, T. Murray, E. Ward, E.A. Samuels, R.C. Tiwari, A. Ghafoor, et al., Cancer statistics, 2005, CA Cancer J Clin 55 (2005), 10-30
18. J. Kasturi and A.K. Saraya, Platelet functions in dysproteinaemia, Acta Haematologica 59 (1978), 104-113
19. R. Kotlin, A. Sobotkova, T. Riedel, P. Salaj, J. Suttnar, Z. Reicheltova et al., Acquired dysfibrinogenemia secondary to multiple myeloma, Acta Haematol 120 (2008), 75-81
20. S.Y. Kristinsson, O. Landgren, P.W. Dickman, A.R. Derolf and M. Bjorkholm, Patterns of survival in multiple myeloma: A population-based study of patients diagnosed in Sweden from 1973 to 2003, J Clin Oncol 25 (2007), 1993-1999
21. H.C. Kwaan, M. Levin, S. Sakurai, S. Kucuk, M.W. Riooney, L.J. Lis and J.W. Kaufman, Digital ischemia and gangrene due to red blood cell aggregation induced by acquired dysfibrinogenemia, J Vasc Surg 26 (1997), 1061-1068
22. H.C. Kwaan and J. Wang, Hyperviscosity in polycythemia vera and other red cell abnormalities, Semin Thromb Hemost 29 (2003), 451-458
23. R.A. Kyle and S.V. Rajkumar, Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma, Leukemia 23 (2009), 3-9
24. R.A. Kyle and S.V. Rajkumar, Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma, Curr Hematol Malig Rep 5 (2010), 62-69
25. R.A. Kyle and S.V. Rajkumar, Multiple myeloma, N Engl J Med 351 (2004), 1860-1873
26. I. Levin, L. Helpman, S. Maslovitz, S., D. Pauzner, I. Shapira, R. Gamzu and B. Almog, Erythrocyte aggregation is increased in preterm premature rupture of the membranes, Eur J Obste Gynecol Reprod Biol 125 (2006), 199-201
27. L.H. Miller, S. Usami and S. Chien, Alteration in the rheologic properties of Plasmodium Knowlesi-infected red cells. A possible mechanism for capillary obstruction, J Clin Invest 50 (1971), 1451-1455
28. P.C. Obiefuna, Rouleaux formatioA. n in sickle cell traits, J Tropic Med Hygiene 94 (1991), 42-44
29. R.G. Owen, S.P. Treon, A. Al-Katib, R. Fonseca, R.M. Greipp, M.L. McMaster, et al., Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia, Semin Oncol 30 (2003), 110-115
30. A. Palumbo and K. Anderson, Multiple myeloma, N Engl J Med 364 (2011), 1046-1060
31. R. Penny, P.A. Castaldi and H.M. Whitsed, Inflammation and haemostasis in paraproteinaemias, Br J Haematol 20 (1971), 35-44
32. H.A. Perkins, M.R. MacKenzie and H.H. Fudenberg, Hemostatic defects in dysproteinemias, Blood 35 (1970), 695-707
33. R.A. Kyle, T.M. Therneau, S.V. Rajkumar, E.D. Remstein, J.R. Offord, D.R. Larson et al. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Semin. Oncol 30 (2003), 169-171
34. M. Ramos-Casals, J.H. Stone, M.C. Cid, and X.X. Bosch The cryoglobulinaemias, Lancet 379 (2012), 348-360
35. M.W. Rampling, Red cell aggregation and yield stress, in: Clinical Blood Rheology, G.D.O. Lowe, ed., Boca Raton, Florida, U.S.A., CRC Press, Inc. (1988), pp. 45-64.